Welcome to Osteoporosis: New Deliveries in Bone Health sponsored by Mission Pharmacal. Join Sol Epstein, MD, FRCP, FACP, professor of medicine and geriatrics at Mt. Sinai School of Medicine in New York, and adjunct professor of medicine at the University of Pennsylvania. In this series, Dr. Epstein discusses the importance of screening patients who have or who are at risk for developing osteoporosis. He provides clinical updates on current and emerging therapies, focusing on efficacy, safety, and their role in providing fracture prevention andreduction. Lastly, Dr Epstein reviews how bisphosphonates were the first class of drugs to be approved for the treatment of osteoporosis-and why they remain the foundation of treatment to this day.
Dr. Epstein is a paid consultant for Mission Pharmacal.
You need to be logged in to save this episode to a playlist.
You must be logged in to display playlists.